Pharmaceutical Market Europe • July/August 2024 • 73
APPOINTMENTS
Sanofi
Audrey Duval Derveloy
Sanofi has appointed Audrey Duval Derveloy as executive vice president, global head of corporate affairs. Duval Derveloy brings extensive pharmaceutical experience across a variety of leadership roles to her new position. She most recently served as president and country lead of Sanofi France. Prior to this, Duval Derveloy served as president of the health industries and technologies strategic sector committee at the French Ministry of the Economy, Finance and Industrial and Digital Sovereignty. Earlier in her career, Duval Derveloy worked at Novartis for nearly a decade in a variety of roles, including country president for the company’s operations in Ireland, which followed on from her position as business franchise head for ophthalmology in France. She also previously held positions at Pfizer, most recently as inflammation medical advisor.
Eli Lilly
Melissa Seymour
Eli Lilly has appointed Melissa Seymour as executive vice president of global quality. Seymour holds over two decades of experience within the pharmaceutical and biotechnology industries. She has most recently been serving as chief quality officer at Bristol Myers Squibb. Prior to this, she held several roles at Biogen, most recently as chief quality officer.
NodThera
Daniel Swisher
NodThera has appointed Daniel Swisher as chief executive officer. Swisher holds over three decades of leadership expertise in the life sciences industry. He most recently served as strategic advisor at Jazz Pharmaceuticals, after serving as president and chief operating officer. Prior to this, Swisher served as chief executive officer and president of Sunesis Pharmaceuticals.
IRLAB Therapeutics
Kristina Torfgård
IRLAB Therapeutics has appointed Kristina Torfgård as chief executive officer. Torfgård has over three decades of pharmaceutical and biopharmaceutical experience. She has most recently been serving as chief executive officer of Alzinova. She has also held several senior positions at AstraZeneca in both early and late-stage research and development.
Connect Biopharma
Barry Quart
Connect BioPharma has appointed Barry Quart as chief executive officer. Quart brings more than three decades of extensive leadership experience at biotechnology and pharmaceutical companies to his new role. He most recently served as chief executive officer at Heron Therapeutics. Prior to this, Quart was president, chief executive officer and co-founder of Ardea Biosciences.
Connect Biopharma
David Szekeres
Connect Biopharma has appointed David Szekeres as president. Szekeres has a wealth of experience in leadership roles. He most recently served as executive vice president and chief operating officer at Heron Therapeutics. Prior to this, Szekeres was chief business officer, chief financial officer and general counsel at Regulus Therapeutics.
Illumina
Everett Cunningham
Illumina has appointed Everett Cunningham as chief commercial officer. Cunningham brings over 25 years of commercial experience to his new role. He most recently served as chief commercial officer at Exact Sciences. Prior to this, he held various senior leadership roles at Quest Diagnostics, GE Healthcare and Pfizer.
Connect Biopharma
Kleanthis Xanthopoulos
Connect Biopharma has appointed Kleanthis Xanthopoulos as chair to its board of directors. Xanthopoulos brings more than 25 years of experience in the biotechnology and pharmaceutical industries to his new role. He is a co-founder, chairman and chief executive officer of Shoreline Biosciences, and was previously chief executive officer of IRRAS.
Viatris
Rogerio Vivaldi
Viatris has appointed Rogerio Vivaldi to its board of directors. Vivaldi brings over three decades of extensive experience to his new position. He previously served as president and chief executive officer of Sigilon Therapeutics, and has held a range of senior roles at companies including Bioverativ, Spark Therapeutics, Minerva Neurosciences and Genzyme.
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services